Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-Current Debt
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Change in Account Payables: 2020-2025

Historic Change in Account Payables for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to $10.5 million.

  • CureVac N.V's Change in Account Payables rose 152.78% to $10.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$81.8 million, marking a year-over-year decrease of 289.87%. This contributed to the annual value of -$150.2 million for FY2024, which is 363.88% down from last year.
  • As of Q2 2025, CureVac N.V's Change in Account Payables stood at $10.5 million, which was up 213.31% from -$9.3 million recorded in Q1 2025.
  • CureVac N.V's Change in Account Payables' 5-year high stood at $199.8 billion during Q2 2021, with a 5-year trough of -$148.5 billion in Q4 2021.
  • Moreover, its 3-year median value for Change in Account Payables was -$10.0 million (2023), whereas its average is -$18.4 million.
  • Its Change in Account Payables has fluctuated over the past 5 years, first slumped by 295,971.60% in 2022, then skyrocketed by 152.78% in 2025.
  • Quarterly analysis of 5 years shows CureVac N.V's Change in Account Payables stood at -$148.5 billion in 2021, then surged by 100.02% to $36.3 million in 2022, then soared by 65.56% to $60.1 million in 2023, then plummeted by 109.95% to -$6.0 million in 2024, then spiked by 152.78% to $10.5 million in 2025.
  • Its Change in Account Payables was $10.5 million in Q2 2025, compared to -$9.3 million in Q1 2025 and -$6.0 million in Q4 2024.